Our mission is to improve patient outcomes at a reduced cost by applying artificial intelligence to diagnostic imaging. We believe that current cardiovascular diagnostics are often either expensive, burdensome to the patient, or not sufficiently accurate. Medical imaging offers an economically efficient and non-invasive method for capturing patient health information, but additional tools are needed to realize its full diagnostic power. Our software is part of that solution, and we will continue to develop additional applications to support sustainable, enhanced patient care.


What is now Elucid began studies in 2009 with a mission to better understand the underlying cause of heart attacks and strokes: subclinical atherosclerosis. After years of promising results and success as a CRO, Elucid sought to translate these findings into a usable clinical tool to deliver better care and help reduce the number of heart attacks and strokes. The tool had to be accurate, efficient, and cost-effective. With those requirements in mind, Elucid released vascuCAP (now elucid vivo) to bring this knowledge to the market and improve the diagnosis and treatment of cardiovascular disease for patients across the globe. Elucid continues to innovate and develop novel, AI-enabled solutions to healthcare’s toughest challenges.




Scientific Advisory Board